SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Emre M. What causes cognitive dysfunction in Parkinson's disease? Mov Disord 2003; 18( Suppl 6): S63S71.
  • 2
    Emre M. Dementia associated with Parkinson's disease. Lancet Neurol 2003; 2: 229237.
  • 3
    Pillon B,Czernecki V,Dubois B. Dopamine and cognitive function. Curr Opin Neurol 2003; 16( Suppl 2): S17S22.
  • 4
    Rinne JO,Rummukainen J,Paljarvi L,Rinne UK. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989; 26: 4750.
  • 5
    Fearnley J,Lees AJ. Parkinson's disease: neuropathology. In: Watts RL,Koller WC, editors. Movement disorders. New York: McGraw-Hill; 1997. p 263278.
  • 6
    Cropley VL,Fujita M,Innis RB,Nathan PJ. Molecular imaging of the dopaminergic system and its association with human cognitive function. Biol Psychiatry 2006; 59: 898907.
  • 7
    Weder BJ,Leenders KL,Vontobel P, et al. Impaired somatosensory discrimination of shape in Parkinson's disease: association with caudate nucleus dopaminergic function. Human Brain Mapping 1999; 8: 112.
  • 8
    Marié RM,Barré L,Dupuyd B,Viaderb F,Deferb G,Baron J-C. Relationships between striatal dopamine denervation and frontal executive tests in Parkinson's disease. Neurosci Lett 1999; 260: 7780.
  • 9
    Rinne JO,Portin R,Ruottinen H, et al. Cognitive impairment and the brain dopaminergic system in Parkinson's disease. Arch Neurol 2000; 57: 470475.
  • 10
    Jokinen P,Bruck A,Aalto S,Forsback S,Parkkola R,Rinne JO. Impaired cognitive performance in Parkinson's disease is related to caudate dopaminergic hypofunction and hippocampal atrophy. Parkins Relat Disord 2009; 15: 8893.
  • 11
    Holthoff-Detto VA,Vieregge P,Kessler J, et al. Discordant twins with Parhnson's disease: positron emission tomography and early signs of impaired cognitive circuits. Ann Neurol 1994; 36: 176182.
  • 12
    Müller U,Wächter T,Barthel H,Reuter M,von Cramon DY. Striatal [123I] β-CIT SPECT and prefrontal cognitive functions in Parkinson's disease. J Neural Transm 2000; 107: 303319.
  • 13
    Duchesne N,Soucy J-P,Masson H,Chouinard S,Bédard M-A. Cognitive deficits and striatal dopaminergic denervation in Parkinson's disease: a single photon emission computed tomography study using 123Iodine-β-CIT in patients ON and OFF levodopa. Clin Neuropharmacol 2002; 25: 216224.
  • 14
    Cropley VL,Fujita M,Bara-Jimenez W, et al. Pre and post synaptic dopamine imaging and its relation with frontostriatal cognitive function in Parkinson's disease: PET studies with [11C]NNC 112 and [18F]FDOPA. Psychiatry Res: Neuroimaging 2008; 163: 171182.
  • 15
    Nagano-Saito A,Kato T,Arahata Y, et al. Cognitive- and motor-related regions in Parkinson's disease: FDOPA and FDG PET studies. NeuroImage 2004; 22: 553561.
  • 16
    Bruck A,Portin R,Lindell A, et al. Positron emission tomography shows that impaired frontal lobe functioning in Parkinson's disease is related to dopaminergic hypofunction in the caudate nucleus. Neurosci Lett 2001; 311: 8184.
  • 17
    Holthoff-Detto VA,Kessler J,Herholz K, et al. Functional effects of striatal dysfunction in Parkinson's Disease. Arch Neurol 1997; 54: 145150.
  • 18
    Calvini P,Rodriguez G,Inguglia F,Mignone A,Guerra IP,Nobili F. The basal ganglia matching tools package for striatal uptake semi-quantification: description and validation. Eur J Nucl Med Mol Imaging 2007; 34: 12401253.
  • 19
    Gelb DJ,Oliver E,Gilman S. Diagnostic criteria for Parkinson's disease. Arch Neurol 1999; 56: 3339.
  • 20
    Katz S,Downs TD,Cash HR,Grotz RC. Progress in development of the index of ADL. Gerontologist 1970; 10: 2030.
  • 21
    Lawton MP,Brody EM. Assessment of older people: self-mantaining and instrumental activities of daily living. Gerontologist 1969; 9: 179186.
  • 22
    Masur DM,Fuld PA,Blau AD,Thal LJ,Levin HS,Aronson MK. Distinguishing normal and demented elderly with selective reminding test. J Clin Exp Neuropsychol 1989; 11: 615630.
  • 23
    Novelli G,Papagno C,Capitani E,Laiacona N,Vallar G,Cappa S. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia Neurologia e Psichiatria 1986; 47: 477506.
  • 24
    Carlesimo GA,Caltagirone C,Gainotti G. The mental deterioration battery: normative data, diagnostic reliability and qualitative analysis of cognitive impairment. The group for the standardization of the mental deterioration battery. Eur Neurol 1996; 36: 378384.
  • 25
    Basso A,Capitani E,Laiacona M. Raven's colored progressive matrices: normative values on 305 adult normal controls. Funct Neurol 1987; 2: 189194.
  • 26
    Spinnler H,Tognoni G. Standardizzazione e taratura Italiana di test neuropsicologici. Ital J Neurol Sci 1987; 6( Suppl 8): 1120.
  • 27
    Amodio P,Wenin H,Del Piccolo F, et al. Variability of trail making test, symbol digit test and line trait test in normal people. A normative study taking into account age-dependent decline and sociobiological variables. Aging Clin Exp Res 2002; 14: 117131.
  • 28
    Barbarotto R,Laiacona M,Frosio R,Vecchio M,Farinato A,Capitani E. A normative study on visual reaction times and two Stroop color-word tests. Ital J Neurol Sci 1998; 19: 161170.
  • 29
    Orsini A,Grossi D,Capitani E,Laiacona M,Papagno C,Vallar G. Verbal and spatial immediate memory span: normative data from 1355 adults and 1112 children. Ital J Neurol Sci 1987; 8: 539548.
  • 30
    Watson YI,Arfken CL,Birge SJ. Clock completion: an objective screening test for dementia. J Am Geriatr Soc 1993; 41: 12351240.
  • 31
    Louis ED. Clinical practice. Essential tremor. N Engl J Med 2001; 345: 887891.
  • 32
    Isaias IU,Canesi M,Benti R, et al. Striatal dopamine transporter abnormalities in patients with essential tremor. Nucl Med Commun 2008; 29: 349353.
  • 33
    Tatsch K,Asenbaum S,Bartenstein P, et al. European association of nuclear medicine. European association of nuclear medicine procedure guidelines for brain neurotransmission SPET using (123)I-labeled dopamine D(2) transporter ligands. Eur J Nucl Med Mol Imaging 2002; 29: BP30BP35.
  • 34
    Hudson HM,Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imag 1994; 13: 601609.
  • 35
    Boccacci P,Bonetto P,Calvini P,Formiconi AR. A simple model for the efficient correction of collimator blur in 3D SPECT imaging. Inverse Problems 1999; 15: 907930.
  • 36
    Sawamoto N,Piccini P,Hotton G,Pavese N,Thielemans K,Brooks DJ. Cognitive deficits and striato-frontal dopamine release in Parkinson's disease. Brain 2008; 131: 12941302.
  • 37
    Song IU,Kim JS,Jeong DS,Song HJ,Lee KS. Early neuropsychological detection and the characteristics of Parkinson's disease associated with mild dementia. Parkinsonism Relat Disord 2008; 14: 558562.
  • 38
    Aarsland D,Brønnick K,Larsen JP,Tysnes OB,Alves G,Norwegian ParkWest Study Group. Cognitive impairment in incident, untreated Parkinson's disease: the Norwegian ParkWest study. Neurology 2009; 72: 11211126.
  • 39
    Tröster AI. Neuropsychological characteristics of dementia with lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for “mild cognitive impairment” and biomarkers. Neuropsychol Rev 2008; 18: 103119.
  • 40
    Abe Y,Kachi T,Kato T, et al. Occipital hypoperfusion in Parkinson's disease without dementia: correlation to impaired cortical visual processing. J Neurol Neurosurg Psychiatry 2003; 74: 419422.
  • 41
    Firbank MJ,Colloby SJ,Burn DJ,McKeith IG,O'Brien JT. Regional cerebral blood flow in Parkinson's disease with and without dementia. NeuroImage 2003; 20: 13091319.
  • 42
    Hu MTM,Taylor-Robinson SD,Ray Chaudhuri K, et al. Cortical dysfunction in non demented Parkinson's disease patients: a combined 31P-MRS and 18FDG PET study. Brain 2000; 123: 340352.
  • 43
    Kuhl DE,Minoshima S,Fessler JA, et al. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease. Ann Neurol 1996; 40: 399410.
  • 44
    Bohnen NI,Kaufer DI,Ivanco LS, et al. Cortical cholinergic function is more severely affected in Parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 2003; 60: 17451748.
  • 45
    Caballol N,Martì MJ,Tolosa E. Cognitive dysfunction and dementia in Parkinson's disease. Mov Disord 2007; 22( Suppl 17): S358S366.
  • 46
    Mayeux F,Fénelon G,Flahault A, et al. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998; 64: 178183.
  • 47
    Busch RM,Farrell K,Lisdahl-Medina K,Krikorian R. Corsi block-tapping task performance as a function of path configuration. J Clin Exp Neuropsychol 2005; 27: 127134.
  • 48
    Scholtissen B,Verhey FR,Adam JJ,Weber W,Leentjens AF. Challenging the serotonergic system in Parkinson's disease patients: effects on cognition, mood, and motor performance. Clin Neuropharmacol 2006; 29: 276285.